The objective of this study is to evaluate the drug-drug interaction potential between BI
201335 and concomitantly administered tenofovir which is used in treatment regimens for HIV
infection and/or Hepatitis B infection. Results of this study will serve as a basis for
guidance of dose adjustments or other precautionary measures when BI201335 and tenofovir are
coadministered.